Recombinant DNA (rDNA) refers to artificial DNA molecules that are created by combining genetic material from different sources. This technology involves the insertion of DNA fragments from one ...

In the context of the NIH Guidelines for Research Involving Recombinant DNA Molecules, recombinant DNA molecules are defined as either: molecules that are constructed outside living cells by joining ...

Recombinant DNA is one of the first stories in modern biotechnology history. The National Museum of American History contains collections which trace this foundational technique of genetic engineering ...

Recombinant DNA technologies developed in the early 1970s enabled scientists to isolate genes of interest and splice them into existing DNA structures. However, as late as the early 1980s, the ...

How did the idea of recombinant protein emerge? Recombinant proteins were proposed by Peter Lobban who was the first person to produce and replicate recombinant DNA in 1972 and 1973. The recombinant ...

In 1986, the Recombivax HB vaccine for hepatitis B was approved for human use in several countries, the culmination of research started by William Rutter, Pablo Valenzuela and colleagues in 1979 on ...

Researchers at the USC School of Pharmacy indicate that recombinant DNA technology may allow for oral administration of drugs that previously could only be given by injection. LOS ANGELES, May 6 - ...

“BIOHAZARDS AT HARVARD,” warns the cover of the June 8, 1976 issue of the Boston Phoenix. “Scientists are on the brink of undertaking revolutionary genetic research which creates new life forms,” the ...

In the summer of 1974, a group of international researchers published an urgent open letter asking their colleagues to suspend work on a potentially dangerous new technology. The letter was a first in ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. In a series of experiments between ...

It will be some time before a vaccine against Covid-19 becomes widely available, but two of Europe’s largest drugmakers, which themselves are also major producers of vaccines, have made a deal to work ...